Whole-body uptake classification and prostate cancer staging in 68Ga-PSMA-11 PET/CT using dual-tracer learning
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1619-7089
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Whole-body uptake classification and prostate cancer staging in 68Ga-PSMA-11 PET/CT using dual-tracer learning ; day:7 ; month:7 ; year:2021 ; pages:1-10
European journal of nuclear medicine and molecular imaging ; (7.7.2021), 1-10
- Klassifikation
-
Medizin, Gesundheit
- Urheber
-
Capobianco, Nicolò
Sibille, Ludovic
Chantadisai, Maythinee
Gafita, Andrei
Langbein, Thomas
Platsch, Guenther
Solari, Esteban Lucas
Shah, Vijay
Spottiswoode, Bruce
Eiber, Matthias
Weber, Wolfgang A.
Navab, Nassir
Nekolla, Stephan G.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00259-021-05473-2
- URN
-
urn:nbn:de:101:1-2021101600534975241508
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 15.04.20252025, 03:37 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Capobianco, Nicolò
- Sibille, Ludovic
- Chantadisai, Maythinee
- Gafita, Andrei
- Langbein, Thomas
- Platsch, Guenther
- Solari, Esteban Lucas
- Shah, Vijay
- Spottiswoode, Bruce
- Eiber, Matthias
- Weber, Wolfgang A.
- Navab, Nassir
- Nekolla, Stephan G.
- SpringerLink (Online service)
Ähnliche Objekte (12)
![Multiparametric dynamic whole-body PSMA PET/CT using [68Ga]Ga-PSMA-11 and [18F]PSMA-1007](/assets/placeholder/searchResultMediaUnknown.png)
Multiparametric dynamic whole-body PSMA PET/CT using [68Ga]Ga-PSMA-11 and [18F]PSMA-1007
68Ga-PSMA I&T PET/CT for primary staging of prostate cancer
68Ga-PSMA I&T PET/CT for primary staging of prostate cancer [Abstract]
44Sc-PSMA-617 for radiotheragnostics in tandem with 177Lu-PSMA-617—preclinical investigations in comparison with 68Ga-PSMA-11 and 68Ga-PSMA-617
68Ga-PSMA and 68Ga-FAPI radioligands in the diagnosis of tumors
68Ga-PSMA PET/CT vs. mpMRI for locoregional prostate cancer staging: correlation with final histopathology
The added value of 68Ga-PSMA PET/CT in anatomical staging of prostatic carcinoma in correlation with the histopathological zonal staging
Comparison of tracer kinetic models for 68Ga-PSMA-11 PET in intermediate-risk primary prostate cancer patients
Impact of PET acquisition durations on image quality and lesion detectability in whole-body 68Ga-PSMA PET-MRI
A novel PSMA-targeting tracer with highly negatively charged linker demonstrates decreased salivary gland uptake in mice compared to [68Ga]Ga-PSMA-11
Cost-effectiveness of the implementation of [68Ga]Ga-PSMA-11 PET/CT at initial prostate cancer staging
Cyclotron-based production of 68Ga, [68Ga]GaCl3, and [68Ga]Ga-PSMA-11 from a liquid target
Multiparametric dynamic whole-body PSMA PET/CT using [68Ga]Ga-PSMA-11 and [18F]PSMA-1007
68Ga-PSMA I&T PET/CT for primary staging of prostate cancer
68Ga-PSMA I&T PET/CT for primary staging of prostate cancer [Abstract]
44Sc-PSMA-617 for radiotheragnostics in tandem with 177Lu-PSMA-617—preclinical investigations in comparison with 68Ga-PSMA-11 and 68Ga-PSMA-617
68Ga-PSMA and 68Ga-FAPI radioligands in the diagnosis of tumors
68Ga-PSMA PET/CT vs. mpMRI for locoregional prostate cancer staging: correlation with final histopathology
The added value of 68Ga-PSMA PET/CT in anatomical staging of prostatic carcinoma in correlation with the histopathological zonal staging
Comparison of tracer kinetic models for 68Ga-PSMA-11 PET in intermediate-risk primary prostate cancer patients
Impact of PET acquisition durations on image quality and lesion detectability in whole-body 68Ga-PSMA PET-MRI
A novel PSMA-targeting tracer with highly negatively charged linker demonstrates decreased salivary gland uptake in mice compared to [68Ga]Ga-PSMA-11
Cost-effectiveness of the implementation of [68Ga]Ga-PSMA-11 PET/CT at initial prostate cancer staging
Cyclotron-based production of 68Ga, [68Ga]GaCl3, and [68Ga]Ga-PSMA-11 from a liquid target
Multiparametric dynamic whole-body PSMA PET/CT using [68Ga]Ga-PSMA-11 and [18F]PSMA-1007
68Ga-PSMA I&T PET/CT for primary staging of prostate cancer
68Ga-PSMA I&T PET/CT for primary staging of prostate cancer [Abstract]
44Sc-PSMA-617 for radiotheragnostics in tandem with 177Lu-PSMA-617—preclinical investigations in comparison with 68Ga-PSMA-11 and 68Ga-PSMA-617
68Ga-PSMA and 68Ga-FAPI radioligands in the diagnosis of tumors
68Ga-PSMA PET/CT vs. mpMRI for locoregional prostate cancer staging: correlation with final histopathology
The added value of 68Ga-PSMA PET/CT in anatomical staging of prostatic carcinoma in correlation with the histopathological zonal staging
Comparison of tracer kinetic models for 68Ga-PSMA-11 PET in intermediate-risk primary prostate cancer patients
Impact of PET acquisition durations on image quality and lesion detectability in whole-body 68Ga-PSMA PET-MRI
A novel PSMA-targeting tracer with highly negatively charged linker demonstrates decreased salivary gland uptake in mice compared to [68Ga]Ga-PSMA-11
Cost-effectiveness of the implementation of [68Ga]Ga-PSMA-11 PET/CT at initial prostate cancer staging